Teleflex Incorporated (TFX) Study Shows 70% Lower CLABSI Hazard With Arrowg+ard

Teleflex reported a peer-reviewed multinational study of 1,750 critically ill patients showing Arrowg+ard-protected CVCs had a 70% lower CLABSI hazard vs plain catheters over 30 days (HR 0.297; 95% CI 0.134-0.658; p=0.003).Material DetailsContext by AI AnalystThis is mid-cycle validation of Telefle…